Citations with the tag: GLAXOSMITHKLINE
Results 1 - 50
// ICIS Chemical Business Americas; 7/9/2007, Vol. 272 Issue 2, p32
The article reports that drug company GlaxoSmithKline is building a $40 million research facility in Shanghai, China.
- Dentine hypersensitivity affects 1 in 3.
// Vital; Fall2012, Vol. 9 Issue 4, p53
The article offers information on the initiative undertaken by Sensodyne team, unit at GlaxoSmithKline, to raise awareness and understanding of dentine hypersensitivity in Great Britain.
- Seroxat firm to drop dependence claim.
// Pulse; 5/19/2003, Vol. 63 Issue 20, p19
Reports on the plans of GlaxoSmithKline PLC (GSK) to change the wording on the patient information leaflet for Seroxat to remove the claim the drug is not addictive. E-mails received by GSK from patients about their experiences of taking Seroxat.
// Formulary; Jun2002, Vol. 37 Issue 6, p280
Features the drug Acova, an argatroban injection from Glaxosmithkline PLC. Efficacy; Administration; Pricing.
- Lucozade to aim Hydro Active at women athletes.
// Marketing (00253650); 3/13/2003, p3
Reports that the company GlaxoSmithKline (GSK) is introducing a variant of its Lucozade Sport brand called Hydro Active, aimed primarily at women. Claims made by the product; Provision for marketing support for the product; Other products launched by the company.
- Sports drinks step up the pace.
Rogers, Daniel // Marketing (00253650); 3/13/2003, p15
Reports on the place made by soft drinks-to-drugs conglomerate GlaxoSmithKilne Inc. with its Leucozade range in the British energy drinks market as of March 13, 2003. Academy launched by the company; Predictions for growth of the range; Competition faced by the sports brand.
- Glaxo expands media pitch to Thailand, India.
Mulchand, Sangeeta // Media: Asia's Media & Marketing Newspaper; 11/15/2002, p4
Reports that pharmaceutical company GlaxoSmithKline (GSK) PLC is reviewing its media assignments in Thailand and India as of November 2002. Media accounts of GSK across Thailand, India and China; Advertising agencies chosen by GSK in Thailand and India to handle its advertising accounts in...
- GlaxoSmithKline upgrades storage to cut back-up time and save �1.3m.
Clark, Lindsay // Computer Weekly; 2/20/2003, p30
Reports on improvements in storage management of the U.S.-based pharmaceuticals company GlaxoSmithKline PLC. Reasons behind the improvements; Information on the deal signed by the company with storage company EMC to provide storage management for its sales and marketing business in Great...
- Repair and protect.
Clark, Lindsay // Vital; Summer2011, Vol. 8 Issue 2, p49
The article offers brief information on the Sensodyne Repair and Protect toothpaste from GlaxoSmithKline.
- GlaxoSmithKline presents a biotech facade.
Dorey, Emma // Nature Biotechnology; Apr2001, Vol. 19 Issue 4, p294
Reports that Great Britain-based pharmaceutical company GlaxoSmithKline (GSK) PLC is restructuring its research and development organization by creating six research units called Centres of Excellence for Drug Discovery. Benefits from restructuring; Plans of GSK to recognize and reward team...
Dorey, Emma // MPR - Pharmacist's Edition; Fall2012, Vol. 6 Issue 3, pA.5
The article offers brief information on the drug Potiga from GlaxoSmithKline.
- Glaxo senles fraud case.
Gallagher, Patrick // Westchester County Business Journal; 7/9/2012, Vol. 48 Issue 28, p11
The article reports that GlaxoSmithKline has settled a health care fraud case worth 3 billion dollars with the U.S. federal government, states and the District of Columbia.
- Patents expiry forces GSK cuts.
Gallagher, Patrick // Process Engineering; Jan2003, Vol. 84 Issue 1, p3
Reports on the decision of pharmaceutical company GlaxoSmithKline PLC to implement layoffs at its plant in Ulversyton, England. Factors that influenced the decision.
- Study eyes denture care errors.
Gallagher, Patrick // Chain Drug Review; 11/8/2010, Vol. 32 Issue 19, p57
The article offers information about Glaxosmithkline (GSK) which has launched Polident MicroClean denture cleansers as many denture wearers make detrimental mistakes which causes growth of bacteria.
- Glaxo Smith Kline The crowd is my�.
Gallagher, Patrick // Campaign (UK); 7/20/2012, Issue 29, p6
The article reports that GlaxoSmithKline has established its role as the official laboratory services provider for London 2012 with its first Great Britain advertising to celebrate anti-doping science.
- GSK Issues Warning About a Batch of H1N1 Vaccine in Canada.
Gallagher, Patrick // Chain Drug Review; 12/7/2009, Vol. 31 Issue 21, p64
The article reports that GlaxoSmithKline PLC has urged the medical staff in Canada to avoid using one batch of its swine flu vaccine due to life threatening reactions including respiratory arrest.
- Brushing up on the over-40s.
Chandiramani, Ravi // Marketing (00253650); 7/4/2002, p48
Introduces 40+, an anti-aging toothpaste from Macleans. Features; Availability; Usability.
- SSRIs gain new indications.
Chandiramani, Ravi // Medical Marketing & Media; Jun2001, Vol. 36 Issue 6, p7
Reports on the approval given by the Food and Drug Administration to the use of GlaxoSmithKline's Paxil for the treatment of generalized anxiety disorder (GAD). Ability to reduce symptoms of GAD; Impact of the move on the market share of Paxil; Decrease recurrent depressive episodes.
- TWO NEW ZEALAND COLLEGE.
M. A. // Medical Marketing & Media; May2007, Vol. 42 Issue 5, p10
A photograph of two New Zealand college students testing the vitamin C content of GlaxoSmithKline's sugary black currant drink Ribena is presented.
- GSK Beats Generic Challenge.
Houlton, Sarah // Pharmaceutical Executive; Feb2003, Vol. 23 Issue 2, p26
Reports on the court rulings on the patent challenges to the antidepressant developed by GlaxoSmithKline in the U.S. Barrier to the introduction of the generic Paxil product; Approval of generic competition; Decline in the pharmaceutical company's share price.
- Promising Anti-Malarial for Sub-Sarharan Africa.
Houlton, Sarah // Pharmaceutical Executive; Oct2003, Vol. 23 Issue 10, p18
Reports on the approval of GlaxoSmithKline PLC's antimalarial drug LapDap in Great Britain. Plan to offer the drug at non-profit prices in Africa; Composition of the drug by chlorproguanil and dapsone.
- GSK Invests in India.
Houlton, Sarah // Pharmaceutical Executive; Dec2003, Vol. 23 Issue 12, p24
Reports on the investment of GlaxoSmithKline in India. Partnership of the company in India.
- Correction - GSK.
Houlton, Sarah // Campaign (UK); 10/23/2009, Issue 42, p4
A correction to the article "GSK calls �300m media review" that was published in the October 16, 2009 issue is presented.
- Repair & Protect at Showcase.
Houlton, Sarah // Vital; Autumn2011, Vol. 8 Issue 3, p55
The article offers brief information on Sensodyne Repair & Protect fluoride toothpaste from GlaxoSmithKline.
Houlton, Sarah // Fortune International (Europe); 10/16/2006, Vol. 154 Issue 7, p13
A correction is presented to the article "Patently Unfair?" in the "Dispatches" section of the September 18, 2006 issue.
- GSK Committed to 'Open Innovation'.
Houlton, Sarah // Chain Drug Review; 10/22/2012, Vol. 34 Issue 18, p90
The article informs of GlaxoSmithKline, a global healthcare company, regarding its healthcare program titled "Open Innovation" that aims to develop solutions for the serious health challenges including tuberculosis (TB).
- GSK considers offloading Lucozade and Ribena brands.
O'Reilly, Lara // Marketing Week (Online Edition); 2/7/2013, p10
The article reports that GlaxoSmithKline (GSK) is considering to sell its Lucozade and Ribena drinks brands.
- Aquafresh midmarket paste launch.
O'Reilly, Lara // Grocer; 6/4/2011, Vol. 234 Issue 8007, p24
The article reports on the launching of the Aquafresh Ultimate toothpaste from GlaxoSmithKline.
- GSK creates support team for retail pharmacists.
O'Reilly, Lara // Chain Drug Review; 3/28/2011, Vol. 33 Issue 6, p11
The article reports on the move of GlaxoSmithKline (GSK) to form a community pharmacy team consisting of pharmacists and other care professionals to provide information and tools to help pharmacists communicate with patients on chronic diseases and other appropriate use of medicines and vaccines...
- New toothpaste relieves hypersensitivty.
O'Reilly, Lara // British Dental Journal; 3/12/2011, Vol. 210 Issue 5, p237
The article offers brief information on Sensodyne Repair & Protect toothpaste from GlaxoSmithKline.
- Sensodyne to repair teeth with Novamin sealant technology.
Julyan, Anna-Marie // Grocer; 3/5/2011, Vol. 234 Issue 7995, p27
The article offers information on the Sensodyne Repair & Protect toothpaste from GSK.
- Free iPhone offered by Lucozade Energy.
Julyan, Anna-Marie // Grocer; 9/18/2010, Vol. 233 Issue 7973, p29
The article reports on the launch of the Win an iPhone Every Hour competition to promote the Lucozade Energy by GlaxoSmithKline in Great Britain in September 2010.
- Reparative toothpaste.
Julyan, Anna-Marie // British Dental Journal; 5/14/2011, Vol. 210 Issue 9, p446
The article offers brief information on the Sensodyne Repair & Protect fluoride toothpaste from GloxoSmithkline (GSK).
- what's new.
Julyan, Anna-Marie // British Dental Journal; 6/9/2001, Vol. 190 Issue 11, p622
Reports on developments related to dentistry in Great Britain as of June 2001. Dental Savings Accounts Ltd.'s launching of a subscription service to dentists; GlaxoSmithKline's support for Macleans Milk teeth; Panadent's offering of a free water dispenser with bioactive glass ionomer I-V TRO.
- GSK donates £1 5 million in aid for Save the Children projects.
Julyan, Anna-Marie // Africa Health; May2013, Vol. 35 Issue 4, p12
The article reports that GlaxoSmithKline, a pharmaceutical company will donate 15 million pounds to the aid agency Save the Children for projects in the democratic Republic of Congo and Kenya.
- Lamotrigine who?
Julyan, Anna-Marie // Drug Utilization Review; Jan2002, Vol. 18 Issue 1, p8
Reports on the materials and suggestions developed by GlaxoSmithKline for pharmacists and physicians to help prevent dispensing errors. Medications involved in the issue; Use of a shelf shouter.
- US fears over salmeterol spark Government warning.
Kelly, Brian // Pulse; 8/25/2003, Vol. 63 Issue 34, p13
Reports on the update ordered by the government on the product information for the antiasthmatic drug Serevent in the U.S. Concerns on the increased risk of asthma episodes and deaths; Drug trial made by GlaxoSmithKline PLC; Action taken by the government about the concerns.
- SCIOS LICENSES NATRECOR TO GLAXOSIMTHKLINE IN EUROPE.
Kelly, Brian // Worldwide Biotech; Feb2002, Vol. 14 Issue 2, p7
Reports on the agreement between GlaxoSmithKline Plc and Scios Inc. to license Natrecor, a drug used for treating acute heart failure.
- REUTERS week.
Kelly, Brian // Warsaw Business Journal; 9/17/2001, Vol. 7 Issue 38, p1
Reports business developments in Warsaw, Poland as of September 2001. Office relocation of Glaxo Smith Kline and Baker & McKenzie; Plan of PSA Peugeot-Citreon and Toyota not to take over the troubled Daewoo FSO; Interview with Ewa Freyberg, Democratic Left Alliance's European Union authority.
- Drug Company Used Ghostwriters to Write Work Bylined by Academics, Documents Show.
Wang, Marian // Pro Publica; 11/28/2010, p11
A blog is presented that discusses the use of ghost writers by pharmaceutical company GlaxoSmithKline for writing medical studies, editorials and textbooks, where physicians has been named as writers.
- GlaxoSmithKline launches Twinrix.
Rosa, Taina // Caribbean Business; 6/28/2001, Vol. 29 Issue 26, p30
No abstract available.
- Glaxo may stop Canadian sales.
Rosa, Taina // Drug Topics; 1/20/2003, Vol. 147 Issue 2, p5
Reports that the GlaxoSmithKline has become the first major drug company, as of January 2003 to threaten to cut off supplies to Canadian wholesalers and retailers who knowingly sell to U.S. customers.
- NEW INDICATIONS.
Rosa, Taina // Drug Topics; 2/17/2003, Vol. 147 Issue 4, p71
Features the Lamictal tablets from GlaxoSmithKline PLC in the U.S.
- Minn. senior group calls for 'Tums down' consumer boycott.
Rosa, Taina // Drug Topics; 3/3/2003, Vol. 147 Issue 5, p8
Reports on the Minnesota Senior Federation's call for a consumer boycott of GlaxoSmithKline's over-the-counter (OTC) drugs.
- NEW INDICATIONS.
Rosa, Taina // Drug Topics; 6/2/2003, Vol. 147 Issue 11, p77
Reports on the approval of an indication for Coreg, a beta-adrenergic blocking agent from GlaxoSmithKline.
- Distributors mull supply options at GlaxoSmithKline conference.
Frederick, James // Drug Store News; 6/25/2001, Vol. 23 Issue 8, p110
Presents information on the 2001 Glaxo-SmithKline Industry Conference titled `New Realities for the Pharmaceutical Supply Chain.' Observation of Adam Fein of Pembroke Consulting about the pharmaceutical supply chain; Major wholesale drug companies that sent representatives at the event; What...
- GSK pharmacy discount plan draws cautious response.
Frederick, James // Drug Store News; 10/22/2001, Vol. 23 Issue 16, p1
Presents information on the discount program of GlaxoSmithKline for senior Medicare recipients in the United States. Purpose of the program; Concerns on the discount program; Qualifications for the discount program.
- GSK to appeal court ruling.
Frederick, James // Drug Store News; 1/21/2002, Vol. 24 Issue 1, p37
Reports on the plan of GlaxoSmithKline to appeal a United States federal court ruling on the expiration of the patent on the antibiotic Augmentin. Date of the patent expiration; Details of the ruling; Information on other patents covering Augmentin.
- Just what the doctor ordered.
Ball, Sarah // Employee Benefits; Oct2001, p36
Discusses the corporate strategy on international benefits for employees of GlaxoSmithKline (GSK). Differences between the employee benefits packages of Glaxo Wellcome and SmithKline Beecham; Aim of GSK for its top employees; Impact of entrepreneurship and innovation on the international...
- CSK injects �320m into pension fund.
Ball, Sarah // Employee Benefits; Mar2003, p9
Reports on the amount provided by GlaxoSmithKline PLC to the company's pension fund.